Microcarrier Market worth $2.9 billion | Thermo Fisher Scientific (US), Merck (Germany), Sartorius AG (Germany) and Danaher Corporation (US)

The report "Microcarrier Market by Equipment (SUB, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Microcarrier (Cationic, Collagen), Application (Vaccine, Cell & Gene Therapy), End User (Pharma, Biopharma, CROs, CMOs) - Global Forecast to 2026", is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period. Rising demand for cell-based vaccines, technological advancements, investments for cell and gene research, and growing preference for single-use technologies are the key factors supporting the growth of the market. However, the high cost of cell biology research, limitations in the production of high-density, and microcarrier-cell detachments issues are expected to hinder the overall growth rate.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139831731&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

The Rising demand for cell-based vaccines, technological advancements, investments for cell and gene research, and growing preference for single-use technologies are the key factors supporting the growth of the market. However, the high cost of cell biology research, limitations in the production of high-density, and microcarrier-cell detachments issues are expected to hinder the overall growth rate.

Consumables accounted for the largest share of microcarriers market

Based on product, the market is segmented into consumables and equipment. Consumables dominated the market in 2020. The large share of this segment can be attributed to recent product launches and repeated purchase of high amount of media for various applications.

Biopharmaceutical Production segment accounted for the largest share of market

Based on application, the microcarriers market is categorized into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine and other applications. The biopharmaceutical production application segment dominated the market in 2020. This is due to commercial expansion of major pharmaceutical companies and growing regulatory approvals for the production of cell culture-based vaccines.

The contract research organizations and contract manufacturing organizations is the fastest-growing end user segment of the microcarriers market

Based on end users, the market is segmented into pharmaceutical & biopharmaceutical companies, contract research organizations & contract manufacturing organizations, academic and research institutes and other applications.

The contract research organizations & contract manufacturing organizations segment is expected to grow at the highest rate during the forecast period owing to bioprocessing facility expansion by prominent market players and increasing investments in biopharmaceutical industry.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=139831731&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

North America accounted for the largest share of the microcarriers market

The market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). In 2020, North America accounted for the largest share of the global market, followed by Europe. This market is primarily driven by strong government support for stem cell research, and presence of well-established pharmaceutical companies and recent regulatory approvals for biologics.

The prominent players operating in the microcarriers market are Thermo Fisher Scientific (US), Merck (Germany), Sartorius AG (Germany) and Danaher Corporation (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139831731&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.